A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

The results now are set to go alongside the company’s BLUE-C trial as part of an FDA submission for the cancer detecting ...

As it works to diversify its methods for catching early cases of colorectal cancer, Exact Sciences has put forward clinical ...

Exact Sciences (EXAS) stock rises as company announces release of data for blood-based cancer test on August 16. Read more ...

Thank you for joining us for Exact Sciences' second quarter 2024 conference call. On the call today are Kevin Conroy, the ...

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced performance ...

Scarcely a day goes by when Kevin Conroy, the chief executive of cancer test manufacturer Exact Sciences, doesn't talk about colon cancer. But last month, it hit closer to home when Conroy's ...

Everyone is still mourning the passing of Kevin Conroy, the eternal voice of animated Batman across dozens of projects and multiple decades. The actor died in 2022 from cancer. However ...

Exact Sciences chairman and CEO Kevin Conroy said: “We took a unique scientific approach to develop this test by combining a novel panel of markers. This led to data that improve upon what we ...

“The Exact Sciences team is constantly innovating to help close the screening gap,” said Kevin Conroy, chairman and CEO, Exact Sciences. “The insights that led to this innovation reflect our ...